Avanos Medical Inc
Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including… Read more
Avanos Medical Inc (AVNS) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: 0.036x
Based on the latest financial reports, Avanos Medical Inc (AVNS) has a cash flow conversion efficiency ratio of 0.036x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($28.20 Million) by net assets ($778.20 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Avanos Medical Inc - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how Avanos Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Avanos Medical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Avanos Medical Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Southern Missouri Bancorp Inc
NASDAQ:SMBC
|
0.029x |
|
Start Group
SHG:600734
|
-0.057x |
|
Xi'an Manareco New Materials Co.Ltd
SHG:688550
|
0.045x |
|
Meren Energy
ST:MER
|
0.166x |
|
AKTR
AT:AKTR
|
N/A |
|
Ronglian Group Ltd
SHE:002642
|
-0.030x |
|
A-Zenith Home Furnishings Co Ltd
SHG:603389
|
-0.230x |
|
Antin Infrastructure Partners
LSE:0AA5
|
0.415x |
Annual Cash Flow Conversion Efficiency for Avanos Medical Inc (2011–2025)
The table below shows the annual cash flow conversion efficiency of Avanos Medical Inc from 2011 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $778.20 Million | $74.70 Million | 0.096x | -21.02% |
| 2024-12-31 | $828.50 Million | $100.70 Million | 0.122x | +363.78% |
| 2023-12-31 | $1.24 Billion | $32.40 Million | 0.026x | -62.77% |
| 2022-12-31 | $1.29 Billion | $90.90 Million | 0.070x | +2.46% |
| 2021-12-31 | $1.27 Billion | $87.30 Million | 0.069x | +3553.25% |
| 2020-12-31 | $1.26 Billion | $-2.50 Million | -0.002x | +96.62% |
| 2019-12-31 | $1.27 Billion | $-74.50 Million | -0.059x | +47.54% |
| 2018-12-31 | $1.30 Billion | $-145.60 Million | -0.112x | -194.60% |
| 2017-12-31 | $1.22 Billion | $144.20 Million | 0.119x | -30.72% |
| 2016-12-31 | $1.10 Billion | $188.80 Million | 0.171x | +85.16% |
| 2015-12-31 | $1.06 Billion | $97.60 Million | 0.092x | -6.75% |
| 2014-12-31 | $1.49 Billion | $147.90 Million | 0.099x | -7.86% |
| 2013-12-31 | $2.08 Billion | $223.80 Million | 0.108x | +9.22% |
| 2012-12-31 | $2.06 Billion | $202.60 Million | 0.099x | -- |
| 2011-12-31 | $0.00 | $139.60 Million | x | -- |